Treatment of Myasthenia Gravis
- 11 April 2018
- journal article
- research article
- Published by Elsevier BV in Neurologic Clinics
- Vol. 36 (2), 311-337
- https://doi.org/10.1016/j.ncl.2018.01.011
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravisBMC Neurology, 2011
- Comparison of IVIg and PLEX in patients with myasthenia gravisNeurology, 2011
- A systematic review of population based epidemiological studies in Myasthenia GravisBMC Neurology, 2010
- Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravisEuropean Journal of Neurology, 2009
- Complications of therapeutic plasma exchange: A prospective study of 1,727 proceduresJournal of Clinical Apheresis, 2007
- Long-term follow-up after thymectomy for myasthenia gravis: thoracoscopic vs openJournal of Pediatric Surgery, 2006
- The Early Toxicology of PhysostigmineToxicological Reviews, 2006
- Preliminary Risk-Benefit Assessment of Mycophenolate Mofetil in Transplant RejectionDrug Safety, 1997
- Preliminary Results of a Double-Blind, Randomized, Placebo-Controlled Trial of Cyclosporine in Myasthenia GravisThe New England Journal of Medicine, 1987
- Plasmapheresis and Immunosuppressive Drug Therapy in Myasthenia GravisThe New England Journal of Medicine, 1977